Format

Send to

Choose Destination
Bioorg Med Chem Lett. 2012 May 1;22(9):3095-9. doi: 10.1016/j.bmcl.2012.03.065. Epub 2012 Mar 21.

Quinolinyl- and phenantridinyl-acetamides as bradykinin B1 receptor antagonists.

Author information

1
Gedeon Richter Plc., Budapest 10. POB 27, H-1475, Hungary. j.eles@richter.hu

Abstract

A new series of quinolinyl- and phenantridinyl-acetamides were synthesizer and evaluated against bradykinin B1 receptor. In vitro metabolic stability data were reported for the key compounds.The analgesic effect of compound 20 from the phenantridine series was proved in-vivo.

PMID:
22483585
DOI:
10.1016/j.bmcl.2012.03.065
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center